Anticorps Recombinant de lapin anti-TRAIL/CD253
TRAIL/CD253 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
CoraLite® Plus 647 Fluorescent Dye
CloneNo.
241419D2
N° de cat : CL647-98139
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | IFN-a treated human PBMCs, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
CL647-98139 cible TRAIL/CD253 dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | tumor necrosis factor (ligand) superfamily, member 10 |
| Masse moléculaire calculée | 281 aa, 33 kDa |
| Numéro d’acquisition GenBank | BC032722 |
| Symbole du gène | TRAIL |
| Identification du gène (NCBI) | 8743 |
| Conjugaison | CoraLite® Plus 647 Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 654 nm / 674 nm |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide and 0.5% BSA |
| Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
TRAIL, also known as CD253 or TNFSF10 (tumor necrosis factor superfamily member 10), is a typical death ligand expressed on natural killer cells and cytotoxic T lymphocytes. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. TRAIL induces apoptotic cell death in cancer by binding to its functional death receptors, death receptor (DR) 4 (TNFRSF10A/TRAIL-R1) and DR5 (TNFRSF10B/TRAIL-R2) to activate the extrinsic apoptosis pathway. TRAIL also activates c-Jun N-terminal kinase (MAPK8/JNK) and the transcription factor nuclear factor-κB (NFκB). The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for CL Plus 647 TRAIL/CD253 antibody CL647-98139 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

